1. Home
  2. FPH vs CLLS Comparison

FPH vs CLLS Comparison

Compare FPH & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five Point Holdings LLC

FPH

Five Point Holdings LLC

N/A

Current Price

$5.16

Market Cap

383.2M

Sector

Finance

ML Signal

N/A

Logo Cellectis S.A.

CLLS

Cellectis S.A.

N/A

Current Price

$3.19

Market Cap

394.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FPH
CLLS
Founded
2009
1999
Country
United States
France
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
383.2M
394.4M
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
FPH
CLLS
Price
$5.16
$3.19
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.33
AVG Volume (30 Days)
179.5K
16.7K
Earning Date
04-23-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$110,020,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.98
P/E Ratio
$11.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.60
$2.35
52 Week High
$6.64
$5.48

Technical Indicators

Market Signals
Indicator
FPH
CLLS
Relative Strength Index (RSI) 49.95 56.29
Support Level $4.89 $2.94
Resistance Level $5.37 $3.40
Average True Range (ATR) 0.13 0.17
MACD -0.01 0.06
Stochastic Oscillator 30.65 75.22

Price Performance

Historical Comparison
FPH
CLLS

About FPH Five Point Holdings LLC

Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its four reportable segments are Valencia, San Francisco, Great Park, and Hearthstone. It derives the majority of revenue from the Great Park segment, which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: